Strategy and activity discussion : retail price disclosure of prescription drugs / Bureau of Consumer Affairs.: RG23-130/1977E-PDF
"Adequate price disclosure, a major ingredient found in all other consumer purchasing decisions, is practically non-existent in the dispensing of prescription drugs and appears to severely restrict consumer choice and free market competition. In May, 1977, Mediaspec Inc. submitted "A Report on Prescription Drug Price Disclosure" commissioned by the Bureau of Consumer Affairs exploring this issue, and Consumer Services Branch, in collaboration with Consumer Research Branch, was asked to evaluate the findings and conceive a complete strategy for Bureau action. Based on our evaluation and investigation, and with the concurrence of Consumer Research Branch, this paper proposes what we believe to be the most desirable course of action for the Bureau"--Introduction.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.883880&sl=0
| Department/Agency |
|
|---|---|
| Title | Strategy and activity discussion : retail price disclosure of prescription drugs / Bureau of Consumer Affairs. |
| Publication type | Monograph |
| Language | [English] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | 1 online resource (1 volume (various pagings)) : charts |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: